| 14819-7 |
Lymphocytes/Leukocytes |
NFr |
Bronchial |
Pt |
Qn |
Manual count |
|
ACTIVE |
Lymphocytes/Leukocytes in Bronchial specimen by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
14819-7 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Lymphocytes NFr Bronch Manual |
|
|
|
Y |
|
Bro; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 1482-9 |
Galactose^30M post 40 g galactose PO |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Galactose [Mass/volume] in Blood --30 minutes post 40 g galactose PO |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
1482-9 |
|
|
|
|
Observation |
|
|
|
0 |
Galactose 30M p 40 g Gal PO Bld-mCnc |
|
|
|
Y |
|
30M p 40 g Gal PO; After; Blood; Cerebrose; CHEMISTRY.CHALLENGE TESTING; Galactose tolerance test; Level; Mass concentration; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.4 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 14820-5 |
Lymphocytes/Leukocytes |
NFr |
Plr fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Lymphocytes/Leukocytes in Pleural fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
14820-5 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Lymphocytes NFr Plr Manual |
|
|
|
Y |
|
HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Percent; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 14821-3 |
Lymphocytes/Leukocytes |
NFr |
Periton fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Lymphocytes/Leukocytes in Peritoneal fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
14821-3 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Lymphocytes NFr Prt Manual |
|
|
|
Y |
|
Ascites; Ascitic fluid; Ascitis; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Percent; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 14822-1 |
Lymphocytes/Leukocytes |
NFr |
Synv fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Lymphocytes/Leukocytes in Synovial fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
14822-1 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Lymphocytes NFr Snv Manual |
|
|
|
Y |
|
HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 14823-9 |
Macrophages/Leukocytes |
NFr |
Bronchial |
Pt |
Qn |
Manual count |
|
ACTIVE |
Macrophages/Leukocytes in Bronchial specimen by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
14823-9 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Macrophages NFr Bronch Manual |
|
|
|
Y |
|
Bro; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Macrop; Macrophage; Macros; Macrphg; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 14824-7 |
Magnesium |
PrThr |
Calculus |
Pt |
Ord |
|
|
ACTIVE |
Magnesium [Presence] in Stone |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
14824-7 |
|
|
|
|
Observation |
|
|
|
0 |
Magnesium Stone Ql |
|
|
|
|
|
Calc; Calculi; Chemistry; Gastro; Gastroenterology; GI; Kidney; MAG; Magnes; Mg; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Stn; Stone; Stones |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14825-4 |
Maprotiline |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Maprotiline [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14825-4 |
|
|
|
|
Both |
|
|
|
0 |
Maprotiline SerPl-sCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Ludiomil; Novartis; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.34 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 14826-2 |
Meperidine |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
Meperidine [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
14826-2 |
|
|
|
|
Both |
|
|
|
0 |
Meperidine Gast Ql |
|
|
|
|
|
Addiction; Algil; Alodan; Centralgine; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; Ordinal; Pethidine; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14827-0 |
Mesoporphyrin |
SCnc |
Stool |
Pt |
Qn |
|
|
ACTIVE |
Mesoporphyrin [Moles/volume] in Stool |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14827-0 |
|
|
|
|
Observation |
|
|
|
0 |
Mesopor Stl-sCnc |
|
|
|
Y |
|
Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Concentration |
2.42 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 14828-8 |
Mesothelial cells/Leukocytes |
NFr |
Pericard fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Mesothelial cells/Leukocytes in Pericardial fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
14828-8 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Mesothl Cell NFr Pcar Manual |
|
|
|
Y |
|
Cardio; Cardiology; Cell; Cellularity; Heart Disease; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mesothl; Mesothl Cell; Number Fraction; PCAR; Percent; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 14829-6 |
Mesothelial cells/Leukocytes |
NFr |
Plr fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Mesothelial cells/Leukocytes in Pleural fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
14829-6 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Mesothl Cell NFr Plr Manual |
|
|
|
Y |
|
Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mesothl; Mesothl Cell; Number Fraction; Percent; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 1483-7 |
Galactose^post 40 g dose PO |
MRat |
Urine |
5H |
Qn |
|
|
ACTIVE |
Galactose [Mass/time] in 5 hour Urine --post 40 g dose PO |
|
MIN |
DefinitionDescription |
|
|
g/5 H |
|
|
|
|
|
|
CHAL |
|
1483-7 |
|
|
|
|
Observation |
|
|
|
0 |
Galactose p 40 g PO 5h Ur-mRate |
|
|
|
Y |
|
5 hours; 5.0Hr; 5HR; After; Cerebrose; CHEMISTRY.CHALLENGE TESTING; Galactose tolerance test; Mass rate; mRate; p 40 g PO; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.44 |
1 |
|
|
|
|
|
|
|
g/(5.h) |
|
|
|
0 |
| 14830-4 |
Mesothelial cells/Leukocytes |
NFr |
Periton fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Mesothelial cells/Leukocytes in Peritoneal fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
14830-4 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Mesothl Cell NFr Prt Manual |
|
|
|
Y |
|
Ascites; Ascitic fluid; Ascitis; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mesothl; Mesothl Cell; Number Fraction; Percent; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 14831-2 |
Metanephrine/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Metanephrine/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
mmol/mol creatinine |
|
|
|
|
|
|
CHEM |
|
14831-2 |
|
|
|
|
Observation |
|
|
|
0 |
Metaneph/Creat Ur-sRto |
|
|
|
Y |
|
Chemistry; CR; Crea; Creat; Metaneph; Metanephrne; Metenephrine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
mmol/mol{creat} |
|
|
|
0 |
| 14832-0 |
Metanephrines |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Metanephrines [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
14832-0 |
|
|
|
|
Both |
|
|
|
0 |
MetanephS Ur-sCnc |
|
|
|
Y |
|
Chemistry; Level; Metanephrine+normetanephrine; MetanephS; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.34 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 14833-8 |
Metanephrines |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Metanephrines [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/d |
|
|
|
|
|
|
CHEM |
|
14833-8 |
|
|
|
|
Both |
|
|
|
0 |
MetanephS 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; Metanephrine+normetanephrine; MetanephS; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
| 14834-6 |
Methamphetamine |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
Methamphetamine [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
14834-6 |
|
|
|
|
Both |
|
|
|
0 |
Methamphet Gast Ql |
|
|
|
|
|
Addiction; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; Methamphet; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14835-3 |
Methanol |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Methanol [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14835-3 |
|
|
|
|
Both |
|
|
|
0 |
Methanol SerPl-sCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; MeOH; Methyl alcohol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 14836-1 |
Methotrexate |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Methotrexate [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L;10-9 mol/L; mol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14836-1 |
|
|
|
|
Both |
|
|
|
0 |
MTX SerPl-sCnc |
|
|
|
Y |
|
Amethoperin; Amethopterin; DRUG/TOXICOLOGY; Drugs; Level; Methotrexat; MTX; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UniversalLabOrders |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 14837-9 |
Methsuximide |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Methsuximide [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14837-9 |
|
|
|
|
Both |
|
|
|
0 |
Methsuximide SerPl-sCnc |
|
|
|
Y |
|
Celontin; DRUG/TOXICOLOGY; Drugs; Level; Mesuximide; Petinutin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.34 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 14838-7 |
Toxoplasma gondii |
PrThr |
Tiss |
Pt |
Ord |
Organism specific culture |
|
ACTIVE |
Toxoplasma gondii [Presence] in Tissue by Organism specific culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
14838-7 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
T gondii Tiss Ql Cult |
|
|
|
|
|
C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; T gondii; Tissue; Tissue, unspecified; Toxo; Toxoplasmosis |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14839-5 |
Trypanosoma sp |
Prid |
Bld.buffy coat |
Pt |
Nom |
Microscopy.light |
|
ACTIVE |
Trypanosoma sp identified in Buffy Coat by Light microscopy |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
14839-5 |
|
Microscopy.light |
|
|
Both |
|
|
|
0 |
Trypanos Buffy Coat Micro |
|
|
|
|
|
Blood; Chagas disease; ID; Identity or presence; Infectious Disease; InfectiousDisease; LM; Micro; Microbiology; Micros; Microscopic; Nominal; Point in time; Random; Sleeping sickness; species; spp; Trypanosomiasis; Trypanosomosis; Trypanosomosis (Tse-Tse borne); WB; Whole blood |
2.79 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
| 1484-5 |
Gastrin^10M post 0.2 U/kg secretin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Gastrin [Mass/volume] in Serum or Plasma --10 minutes post 0.2 U/kg secretin |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
1484-5 |
|
|
|
|
Observation |
|
|
|
0 |
Gastrin 10M p 0.2 U/kg SCT SerPl-mCnc |
|
|
|
Y |
|
10M p 0.2 U/kg SCT; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Total gastrins; Zollinger-Ellison syndrome |
2.34 |
1 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
| 14840-3 |
Trypanosoma sp |
Prid |
CSF |
Pt |
Nom |
Wet preparation |
|
ACTIVE |
Trypanosoma sp identified in Cerebral spinal fluid by Wet preparation |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
14840-3 |
|
Wet preparation |
|
|
Both |
|
|
|
0 |
Trypanos CSF Wet Prep |
|
|
|
|
|
Cerebral spinal fluid; Cerebrospinal Fl; Chagas disease; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Prep; Random; Sleeping sickness; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Trypanosomiasis; Trypanosomosis; Trypanosomosis (Tse-Tse borne); Wet mount; Wet prep |
2.79 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
